Disease · HP_0000713
Comparisons in its trials25
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 25
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Ziprasidone vs Haloperidol: serious adverse events | 0 of 189 | 0 of 187 | 376 | NCT00723606 | Trial comparisons |
| Memantine vs Placebo: serious adverse events | 18 of 182 | 11 of 187 | 369 | NCT00857649 | Trial comparisons |
| ELND005 vs Placebo: serious adverse events | 17 of 175 | 5 of 175 | 350 | NCT01735630 | Trial comparisons |
| Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) vs Placebo (Flexible Dose Range 0.5 to 2 mg/Day): deaths from any cause | 0 of 132 | 1 of 137 | 269 | NCT01922258 | Trial comparisons |
| Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) vs Placebo (Flexible Dose Range 0.5 to 2 mg/Day): serious adverse events | 7 of 132 | 6 of 137 | 269 | NCT01922258 | Trial comparisons |
| Prior Brexpiprazole vs Prior Placebo: deaths from any cause | 0 of 163 | 0 of 96 | 259 | NCT03594123 | Trial comparisons |
| Prior Brexpiprazole vs Prior Placebo: serious adverse events | 6 of 163 | 0 of 96 | 259 | NCT03594123 | Trial comparisons |
| All AVP-786 vs All Placebo: deaths from any cause | 0 of 115 | 0 of 83 | 198 | NCT03095066 | Trial comparisons |
| All AVP-786 vs All Placebo: serious adverse events | 3 of 115 | 0 of 83 | 198 | NCT03095066 | Trial comparisons |
| Citalopram and Psychosocial Intervention vs Placebo and Psychosocial Intervention: serious adverse events | 8 of 94 | 7 of 92 | 186 | NCT00898807 | Trial comparisons |
| Pimavanserin 40 mg vs Placebo: deaths from any cause | 4 of 90 | 4 of 91 | 181 | NCT02035553 | Trial comparisons |
| Pimavanserin 40 mg vs Placebo: serious adverse events | 15 of 90 | 10 of 91 | 181 | NCT02035553 | Trial comparisons |
| 9 mg ITI-007 vs Placebo: deaths from any cause | 0 of 86 | 0 of 89 | 175 | NCT02817906 | Trial comparisons |
| 9 mg ITI-007 vs Placebo: serious adverse events | 2 of 86 | 1 of 89 | 175 | NCT02817906 | Trial comparisons |
| ROLLOVER BREX vs ROLLOVER PLACEBO: deaths from any cause | 0 of 102 | 1 of 62 | 164 | NCT03724942 | Trial comparisons |
| ROLLOVER BREX vs ROLLOVER PLACEBO: serious adverse events | 7 of 102 | 4 of 62 | 164 | NCT03724942 | Trial comparisons |
| Dronabinol vs Placebo: deaths from any cause | 0 of 37 | 0 of 38 | 75 | NCT02792257 | Trial comparisons |
| Dronabinol vs Placebo: serious adverse events | 2 of 37 | 0 of 38 | 75 | NCT02792257 | Trial comparisons |
| 1. IM Olanzapine vs 2. IM Haloperidol Pus Lorazepam: serious adverse events | 0 of 37 | 0 of 30 | 67 | NCT00797277 | Trial comparisons |
| Methadone vs Morphine: serious adverse events | 5 of 20 | 3 of 20 | 40 | NCT01094522 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0000713/comparisons